Dairy products and prostate cancer risk

Nutrition and Cancer

Volumn 62, Issue 3, 2010, Pages 297-299

  Newmark, Harold L ^a   Heaney, Robert P ^b  

^a RUTGERS UNIVERSITY   (United States)

^b CREIGHTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D;

ARTICLE; CALCIUM INTAKE; CANCER RISK; DAIRY PRODUCT; HUMAN; PHOSPHATE INTAKE; PROSTATE CANCER;

ADULT; AGED; CALCIUM; CALCIUM, DIETARY; DAIRY PRODUCTS; HUMANS; MALE; MIDDLE AGED; PHOSPHATES; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 77951138374     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580903407221     Document Type: Article

References (14)

1. Giovannucci E: Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesis. Cancer Causes Control 9, 567-582, 1998.2.
2. Corder EH, Guess HA, Hulka BS, Friedman GD, Sadler M, et al.: Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev 2, 467-472, 1993.
3. Giovannucci E, Rimm EB, Wolk A, Ascherio A, Stampfer MJ, et al.: Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res 58, 442-447, 1998.
4. Chan JM, Giovannucci E, Andersson SO, Yuen J, Adami HO, et al.: Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden). Cancer Causes Control 9, 559-566, 1998.
5. Chan JM, Stampfer MJ,Ma J, Gann PH, Gaziano JM, et al.: Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am J Clin Nutr 74, 549-554, 2001.
6. Vieth R: Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am J Clin Nutr 76, 490-491, 2002.
7. Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, and Holick MF: Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25- hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev 7, 391-395, 1998.
8. Hsu JY, Feldman D, McNeal JE, and Peehl DM: Reduced 1alphahydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition. Cancer Res 61, 2852-2856, 2001.
9. Young MV, Schwartz GG, Wang L, Jamieson DP, Whitlatch LW, et al.: The prostate 25-hydroxyvitamin D-1 alpha-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin D. Carcinogenesis 25, 967-971, 2004.
10. Holick MF: Personal communication, 2005.
11. Portale AA, Halloran BP, Murphy MM, and Morris RC Jr: Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxy vitamin D by determining its production rate in humans. J Clin Invest 77, 7-12, 1986.
12. Institute of Medicine, National Academy of Medicine: Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D and Flouride. Washington, DC: National Academy Press, 1997.
13. Keating FR Jr, Jones JD, Elveback LR, and Randall RV: The relation of age and sex to distribution of values in healthy adults of serum calcium, inorganic phosphorus, magnesium, alkaline phosphatase, total proteins, albumin, and blood urea. J Lab Clin Med 73, 825-834, 1969.
14. Baron JA, Beach M, Wallace K, Grau MV, Sandler RS, et al.: Risk of prostate cancer in a randomized clinical trial of calcium supplementation. Cancer Epidemiol Biomarkers Prev 14, 586-589, 2005. (Pubitemid 40489200)